31 January 2013, 17:00 Central European Time
This free educational webinar is an initiative of the ESMO Personalised Medicine Task Force and sponsored by Thomson Reuters. The first topic will focus on the clinical application of next generation sequencing (NGS) technologies in the thoracic oncology personalised medicine setting.
Learning objectives:
How key aspects of MetaMiner (Oncology) from Thomson Reuters, a collaborative, cancer-specific industry-academic partnering programme, has enabled target and drug response biomarker discovery
How data analysis has been directly applied to personalised cancer therapy
How molecular markers can be used to predict treatment toxicity
How molecular markers are being applied to translational research in thoracic malignancies
Read more and register here.
No comments:
Post a Comment